لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Vongsachang H; Ophthalmic Plastic Surgery Service, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston., Stagner AM; David G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear, Harvard Medical School, Boston., Aronow ME; Retina Service, Massachusetts Eye and Ear, Harvard Medical School, Boston., Wolkow N; Ophthalmic Plastic Surgery Service, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston.; David G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear, Harvard Medical School, Boston.

المصدر: JAMA ophthalmology [JAMA Ophthalmol] 2023 Aug 01; Vol. 141 (8), pp. 801-803.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print Cited Medium: Internet ISSN: 2168-6173 (Electronic) Linking ISSN: 21686165 NLM ISO Abbreviation: JAMA Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Macular Degeneration*/drug therapy , Wet Macular Degeneration*/drug therapy , Choroidal Neovascularization*/drug therapy, Humans ; Endothelial Growth Factors/therapeutic use ; Ranibizumab/therapeutic use ; Angiogenesis Inhibitors/therapeutic use ; Intravitreal Injections ; Retrospective Studies

SCR Disease Name: Uveal melanoma

المؤلفون: Liberman P; Division of Ocular Immunology, Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Departamento de Oftalmología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile., Francis JH; Ocular Oncology Service, Memorial Sloan Kettering, New York, New York, USA., Mehrotra K; Division of Ocular Immunology, Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Tian J; Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., McGarrey MP; Retina Service, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA., Sobol EK; Ocular Oncology Service, Memorial Sloan Kettering, New York, New York, USA., Thorne JE; Division of Ocular Immunology, Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Aronow ME; Retina Service, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA., Berkenstock MK; Division of Ocular Immunology, Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

المصدر: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2023 Apr; Vol. 31 (3), pp. 496-500. Date of Electronic Publication: 2022 Feb 24.

نوع المنشور: Observational Study; Multicenter Study; Journal Article

بيانات الدورية: Publisher: Informa Healthcare Country of Publication: England NLM ID: 9312169 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-5078 (Electronic) Linking ISSN: 09273948 NLM ISO Abbreviation: Ocul Immunol Inflamm Subsets: MEDLINE

مواضيع طبية MeSH: Macular Edema*/surgery , Retinal Neoplasms*/diagnosis , Retinal Neoplasms*/surgery , Lymphoma*, Humans ; Vitreous Body/surgery ; Retrospective Studies ; Neoplasm Recurrence, Local/surgery ; Vitrectomy

المؤلفون: Trofimov AV; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Aronow ME; Ocular Melanoma Center, Massachusetts Eye and Ear, Boston, Massachusetts; ***Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts., Bussière MR; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; *Harvard Medical School, Boston, Massachusetts., Gragoudas ES; Ocular Melanoma Center, Massachusetts Eye and Ear, Boston, Massachusetts; *Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts., Keane FK; *Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; **Harvard Medical School, Boston, Massachusetts., Kim IK; *Ocular Melanoma Center, Massachusetts Eye and Ear, Boston, Massachusetts; **Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts., Shih HA; **Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; ***Harvard Medical School, Boston, Massachusetts., Bhagwat MS; ***Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts; ****Harvard Medical School, Boston, Massachusetts.

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2023 Mar 01; Vol. 115 (3), pp. 810-811.

نوع المنشور: Letter

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Uner OE; Casey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, Oregon., Aronow ME; Retina Service, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts., Mruthyunjaya P; Department of Ophthalmology, Byers Eye Institute, Stanford School of Medicine, Palo Alto, California., Materin MA; Department of Ophthalmology, Duke University Eye Center, Durham, North Carolina; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina., Stacey AW; Department of Ophthalmology, University of Washington, Seattle, Washington., Wilson M; Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, Tennessee; Ocular Oncology Division, St. Jude Children's Research Hospital, Memphis, Tennessee., Afshar A; Ocular Oncology Service, Department of Ophthalmology, Wayne & Gladys Valley Center for Vision, University of California, San Francisco, San Francisco, California., Skalet AH; Casey Eye Institute, Department of Ophthalmology, Oregon Health & Science University, Portland, Oregon; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon; Department of Radiation Medicine, Oregon Health & Science University, Portland, Oregon; Department of Dermatology, Oregon Health & Science University, Portland, Oregon. Electronic address: skalet@ohsu.edu.

المصدر: Ophthalmology. Retina [Ophthalmol Retina] 2023 Mar; Vol. 7 (3), pp. 284-286. Date of Electronic Publication: 2022 Oct 29.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Published by Elsevier Inc. on behalf of American Academy of Ophthalmology Country of Publication: United States NLM ID: 101695048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-6530 (Electronic) Linking ISSN: 24686530 NLM ISO Abbreviation: Ophthalmol Retina Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma* , Uveal Neoplasms*, Humans ; Registries

SCR Disease Name: Uveal melanoma

المؤلفون: Trofimov AV; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: atrofimov@mgh.harvard.edu., Aronow ME; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts., Gragoudas ES; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts., Keane FK; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Kim IK; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts., Shih HA; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Bhagwat MS; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2023 Feb 01; Vol. 115 (2), pp. 501-510. Date of Electronic Publication: 2022 Jul 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE

مواضيع طبية MeSH: Brachytherapy*/methods , Proton Therapy* , Eye Neoplasms*/radiotherapy , Eye Neoplasms*/pathology , Melanoma*/radiotherapy , Melanoma*/pathology, Humans ; Protons ; Radiotherapy Dosage

المؤلفون: Lane AM; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts., Oxenreiter MM; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts., Hashmi M; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts., Aronow ME; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts., Trofimov AV; Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts., Shih HA; Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts., Gragoudas ES; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts., Kim IK; Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear, Boston, Massachusetts. Electronic address: ivana_kim@meei.harvard.edu.

المصدر: Ophthalmology. Retina [Ophthalmol Retina] 2022 Nov; Vol. 6 (11), pp. 1089-1097. Date of Electronic Publication: 2022 May 16.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Published by Elsevier Inc. on behalf of American Academy of Ophthalmology Country of Publication: United States NLM ID: 101695048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-6530 (Electronic) Linking ISSN: 24686530 NLM ISO Abbreviation: Ophthalmol Retina Subsets: MEDLINE

مواضيع طبية MeSH: Protons* , Melanoma*, Humans ; Neoplasm Recurrence, Local ; Retrospective Studies ; Treatment Outcome

SCR Disease Name: Uveal melanoma